Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Growth Hormone for Severe Decrease of Growth Velocity in Children With Anorexia Nervosa
NCT01626833Phase 3Completed
- Sponsor
- Assistance publique - Hôpitaux de Paris
- Start
- Mar 2013
- Primary completion
- Mar 2021
- Modality
- Hormone, rProtein (Recombinant Protein), Biologic
- Countries
- 1
01
Overview
A Phase 3 trial of somatropin in anorexia nervosa (AN), Growth failure (FTT), sponsored by Assistance publique - Hôpitaux de Paris. Started Mar 2013; status: completed.
02
Drugs
somatropin
03
Conditions
anorexia nervosa (AN)Growth failure (FTT)
Beyond the preview
Go deeper on NCT01626833.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01626833.